Pint-Pharma GmbH holds an active UK Companies House registration as an oversea-company (FC030736), meaning it is incorporated outside the UK and maintains a UK branch registration. The company was incorporated in March 2012, according to the filing, and its registered address on the UK record is 'Refer To Parent Registry', the actual UK office location is not published. This is typical for an overseas parent that administers its branch from its home jurisdiction. The company name points to the pharmaceutical sector, though the public register gives no SIC code or business description. No verified web content is available to confirm product lines or specific activities; reasonable inference suggests pharmaceutical research, development, or trade. The key public indicator of activity is the Home Office sponsor licence. Pint-Pharma holds a Worker rating under the Global Business Mobility: UK Expansion Worker route. This route is designed for overseas businesses to send senior or specialist employees to the UK to set up a new commercial presence. It suggests the company is actively planning or implementing a UK expansion, and the licence is a concrete step toward hiring staff. Because the licence is active and the route requires a genuine business plan, the company is likely to be in the early stages of establishing its UK team. The exact number of roles or the size of the UK operation is not stated, but the sponsorship licence itself indicates a hiring need in the near term. Internationally, the company has presence in at least one other jurisdiction (the parent's country), and the UK branch is part of that broader structure.

Pint-Pharma GmbH holds an active UK Companies House registration as an oversea-company (FC030736), meaning it is incorporated outside the UK and maintains a UK branch registration. The company was incorporated in March 2012, according to the filing, and its registered address on the UK record is 'Refer To Parent Registry', the actual UK office location is not published. This is typical for an overseas parent that administers its branch from its home jurisdiction. The company name points to the pharmaceutical sector, though the public register gives no SIC code or business description. No verified web content is available to confirm product lines or specific activities; reasonable inference suggests pharmaceutical research, development, or trade. The key public indicator of activity is the Home Office sponsor licence. Pint-Pharma holds a Worker rating under the Global Business Mobility: UK Expansion Worker route. This route is designed for overseas businesses to send senior or specialist employees to the UK to set up a new commercial presence. It suggests the company is actively planning or implementing a UK expansion, and the licence is a concrete step toward hiring staff. Because the licence is active and the route requires a genuine business plan, the company is likely to be in the early stages of establishing its UK team. The exact number of roles or the size of the UK operation is not stated, but the sponsorship licence itself indicates a hiring need in the near term. Internationally, the company has presence in at least one other jurisdiction (the parent's country), and the UK branch is part of that broader structure.